ArticleFrontiers in pharmacology2024

Cost-effectiveness of immune checkpoint inhibitors in treating metastatic urothelial cancer.

Li-Yu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.